Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Mar 2021 for Virpax Pharmaceuticals, Inc., €592.
Filing timeline
BuySaleThani Jambulingam
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thani Jambulingam: trading record in brief
One trade, one date: on 1 March 2021, Thani Jambulingam disclosed an open-market purchase of €592 in Virpax Pharmaceuticals, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thani Jambulingam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 100 shares@ US$7.16Common Stock, $0.00001 par valueSEC:0001213900-21-012631:0Canonical exit: 18 May 2021 (T+90)
1 of 1 declaration